Research Home | Biomedical Research | Cancer Collaboration | Cancer Center of Excellence | Cancer and Tobacco | Ethics | HRPP & IRB

About The Florida Biomedical Research Programs (FBRP)

The Florida Biomedical Research Programs administered by the Florida Department of Health, Public Health Research Unit, includes two grant-funding programs; the James and Esther King Biomedical Research Program and the Bankhead-Coley Cancer Research Program.

• List of Research Studies:
• Research Studies Funded by the William G. "Bill" Bankhead, Jr., and David Coley Cancer Research Program
• Research Studies Funded by the James and Esther King Biomedical Research Program
• Biomedical Research Advisory Council

About The James and Esther King Biomedical Research Program

In 1999, the Florida Legislature established in section (s.) 215.5602, Florida Statutes (F.S.), a Biomedical Research Program; now known as the James and Esther King Biomedical Research Program, to support research for the prevention, diagnosis, treatment, and/or cure of diseases related to tobacco use. Since its inception, Program funding has come from the interest earned on a $150 million reserve within the Lawton Chiles Endowment Fund, a fund established with monies received from the tobacco industry through Florida's tobacco lawsuit settlement agreement (s. 215.5601,, F.S.). Until 2009, $6 million in additional funds were allocated to the Program annually. Since fiscal year 2009-2010, the Program has received a portion of the revenue deposited into the Health Care Trust Fund from the increased cigarette user fee imposed by s. 210.02, F.S.

The Florida Department of Health administers the James and Esther King Biomedical Research Program (hereafter referred to as "the Program") with the support of a sub-contracting partner, Solix, Inc. The Program also solicits program recommendations and suggestions on policy alternatives from the Biomedical Research Program Advisory Council consistent with Chapter 20, and s. 215.5602, F.S.

The Florida Legislature has given the Program the following goals:

• To research better prevention, diagnosis, treatments, and cures of diseases related to tobacco use and thereby expand the foundation of biomedical knowledge and improve the health of Floridians
• To bring the advances of biomedical research into the training of healthcare workers
• To undertake new initiatives in biomedical research that will attract additional funding and stimulate economic activity in areas related to biomedical research

Any university or research institute in Florida may apply for grant funding to support these goals, and all qualified investigators in the state, regardless of institution, have equal opportunity to compete for funding. All awards are made based on scientific merit, as determined by open competitive peer review.

About The Bankhead-Coley Cancer Research Program

In July 2006, the William G. "Bill" Bankhead, Jr., and David Coley Cancer Research Program (also known as the Bankhead-Coley Cancer Research Program) was established in section (s.) 381.922, Florida Statutes (F.S.). Between 2006 and 2009, $6 to $9 million was allocated to the Program annually. Since fiscal year 2009-2010, the Program has received a portion of the revenue deposited into the Health Care Trust Fund from the increased cigarette user fee imposed by s. 210.02, F.S.

The Florida Department of Health administers the Bankhead-Coley Cancer Research Program (hereafter referred to as "the Program") with the support of a sub-contracting partner, Solix, Inc. The Program also solicits program recommendations and suggestions on policy alternatives from the Biomedical Research Program Advisory Council consistent with Chapter 20, and s. 215.5602, F.S.

Program staff accepts these elements as the framework for establishing goals that are more specific, along with emphasis on the following:

1. Significantly expand cancer research capacity in the state by:
   1. Identifying ways to attract new research talent and attendant national grant-producing researchers to cancer research facilities in this state;
   2. Implementing a peer-reviewed, competitive process to identify and fund the best proposals to expand cancer research institutes in this state;
   3. Funding through available resources for those proposals that demonstrate the greatest opportunity to attract federal research grants and private financial support;
   4. Encouraging the employment of bioinformatics in order to create a cancer informatics infrastructure that enhances information and resource exchange and integration through researchers working in diverse disciplines, to facilitate the full spectrum of cancer investigations;
   5. Facilitating the technical coordination, business development, and support of intellectual property as it relates to the advancement of cancer research;
   6. Aiding in other multidisciplinary research-support activities as they inure to the advancement of cancer research.
2. Improve both research and treatment through greater participation in clinical trials networks by:
   1. Identifying ways to increase adult enrollment in cancer clinical trials;
   2. Supporting public and private professional education programs designed to increase the awareness and knowledge about cancer clinical trials;
   3. Providing tools to cancer patients and community-based oncologists to aid in the identification of cancer clinical trials available in the state;
   4. Creating opportunities for the state's academic cancer centers to collaborate with community-based oncologists in cancer clinical trials networks.
3. Reduce the impact of cancer on disparate groups by:
   1. Identifying those cancers that disproportionately impact certain demographic groups;
   2. Building collaborations designed to reduce health disparities as they relate to cancer.

Any university or research institute in Florida may apply for grant funding to support these goals, and all qualified investigators in the state, regardless of institution, have equal opportunity to compete for funding. All awards are made based on scientific merit, as determined by open competitive peer review.